Aurinia Pharmaceuticals on Alert

Entry level $8.00 = Target price $9.75 = Stop loss $7.50
Possible long term breakout in the stock which has made a nice recovery on the back of earnings surprise.
It's possible it may consolidate for a few days on the market weakness.
Average analysts price target $13 | BUY rating
High 14% short interest
Company profile
Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases particularly lupus nephritis. The company was founded by Robert Foster, Richard Glickman and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
Dec 05
Dec 05
Comment: apologies it went up 120% not 22 BOOOOMMMMMMM
Do you want to GAIN an Edge on Wall Street?

1) Sign Up for our Free Email Newsletter @

2) Sign Up for our Free Text Message Notifications
by Texting 'GAINS' to 67076.

(*It's FREE, however Msg&Data rates may apply
I’m so glad I have this one a shot they went up like 95% in afterhours
Home Stock Screener Forex Screener Crypto Screener Economic Calendar Shows How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Help Center Refer a friend Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out